Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  Identification and characterisation of kinase inhibitors as therapeutics for the treatment of cancer metastasis


   Institute of Integrative Biology

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr D H Bennett, Prof P Eyers  Applications accepted all year round

About the Project

Metastasis, the spreading of cancer cells to different tissues, is clinically the most important process in the progression of most types of cancer. Once tumours undergo metastasis, patient prognosis is often poor because migratory cancer cells, which are widely dispersed and, therefore, not surgically resectable, do not respond to conventional cytotoxic drugs. Therefore, there is an urgent need to identify druggable targets for the development of compounds that have the potential to prevent the spread of cancer cells. This is especially important for the long-term management of inoperable primary tumours that have evolved resistance to initial therapy and to the treatment of cancers that are not diagnosed until the disease has begun to spread, such as cancers of the ovary and pancreas where survival rates are very low. Protein kinases are highly conserved, play critical roles in all the biological processes underlying invasive cell migration and represent important classes of potential therapeutic targets for the treatment of cancer. Building on the results of our genetic screens, we will identify and test new and clinically-approved drugs for their ability to inhibit key pro-migratory kinases and halt invasion in cancer. High-throughput kinase assays screened in the presence of cellular ATP concentrations will facilitate selection of compounds for functional analysis in vivo in a Drosophila model and in a panel of ovarian cancer lines that are resistant or sensitive to conventional chemotherapies. Biomarkers of downstream signalling and drug-resistant kinase alleles will prove target engagement. This project would suit any student with a background in molecular and cellular biology and with an interest in a career in cancer research. Many of the techniques are state-of-the art, which means that there will be good opportunity for career development.

Training:
The student will be associated with active research groups conducting lab-based biochemistry, molecular genetics and cell imaging research highly relevant to the student’s project. Within the groups, several lab members are working on related projects, and adjacent collaborating labs have additional expertise, giving the student access to a large set of other experimentalists to gain advice and intellectual input. The student will be expected to regularly interact with the supervisors to enable rapid progress and to ensure a broad training in the relevant inter-disciplinary approaches. The approaches proposed are state-of-the art (including fluorescence enzyme assays and cell imaging), and the infrastructure and support is exceptionally strong; this means that there will be good career development opportunities for the student. Regular PGR meetings will enable continuous progress checks, so that and technical or other problems can be identified and remedied quickly. Generic skills training will be provided through weekly lab meetings. These will give the student experience of oral presentation of their work, will expose them to other research methods and systems and broaden their scientific outlook. The student will also be expected to attend other seminar series within Liverpool and present their work at a minimum of one international meeting.


Funding Notes

This project is open to applicants who are able to obtain their own funding for tuition fee, consumable laboratory costs and living expenses.

A fees bursary may be available for suitably qualified applicants.

The 2014-15 PhD tuition fees are: UK/EU students £3,996 p.a.; international students £16,847.

In addition fees of between £1,000 and £12,000 per year are required for research costs depending on the type of project. An estimated maintenance allowance of £820 per month is required to cover accommodation, meals, transport etc.

The above figures are for guidance only, details will be provided when an offer is made.


References

Eyers PA (2014) The ‘resistance’ tetrad: amino acid hotspots for kinome-wide design and exploitation of drug-resistant protein kinase alleles. In: Protein kinase inhibitors in Research and Medicine. Methods in Enzymology (in press).

Dar AC et al. (2012) Chemical genetic discovery of targets and anti-targets for cancer polypharmacology. Nature 486(7401):80-4.

Where will I study?